Profile data is unavailable for this security.
About the company
Integra LifeSciences Holdings Corporation is a global medical technology company. The Company manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS business consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield, Bactiseal, and Certas Plus, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. The Company provides instruments that are used in precision, specialty and general surgical procedures. The TT segment is focused on three main areas: complex wound surgery, surgical reconstruction and peripheral nerve repair. The TT segment offers skin and wound repair, bone grafts, and nerve and tendon repair products.
- Revenue in USD (TTM)1.54bn
- Net income in USD67.74m
- Incorporated1989
- Employees3.95k
- LocationIntegra Lifesciences Holdings Corp1100 Campus RoadPRINCETON 08540United StatesUSA
- Phone+1 (609) 275-0500
- Fax+1 (609) 750-4277
- Websitehttps://www.integralife.com/
More ▼
Mergers & acquisitions
| Acquired company | IART:NSQ since announced | Transaction value |
|---|---|---|
| Acclarent Inc | -28.20% | 280.00m |
Data delayed at least 15 minutes, as of Apr 23 2024 21:00 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mesa Laboratories Inc | 212.87m | 948.00k | 551.60m | 698.00 | 583.88 | 1.37 | 15.63 | 2.59 | 0.1751 | 0.1751 | 39.54 | 74.70 | 0.3031 | 2.38 | 5.43 | 304,977.10 | 0.135 | 0.6535 | 0.1438 | 0.7029 | 61.02 | 60.10 | 0.4453 | 1.97 | 1.86 | 0.2604 | 0.3663 | 100.96 | 18.85 | 17.90 | -50.29 | -- | 10.18 | 0.00 |
| Quanterix Corp | 122.37m | -32.33m | 623.43m | 441.00 | -- | 1.79 | -- | 5.09 | -0.8587 | -0.8587 | 3.26 | 9.13 | 0.2848 | 2.64 | 5.51 | 277,478.50 | -7.53 | -15.96 | -8.19 | -17.66 | 57.73 | 52.79 | -26.42 | -53.79 | 9.26 | -- | 0.00 | -- | 15.96 | 26.60 | 66.56 | -- | 20.07 | -- |
| Standard Biotools Inc | 106.34m | -74.66m | 972.94m | 534.00 | -- | -- | -- | 9.15 | -0.9437 | -0.9437 | 1.34 | 2.03 | 0.2981 | 2.66 | 5.76 | 199,138.60 | -20.93 | -28.17 | -26.63 | -33.60 | 47.44 | 51.58 | -70.21 | -74.85 | 1.26 | -13.80 | 0.2801 | -- | 8.57 | -1.20 | 60.73 | -- | 50.06 | -- |
| CTS Corp | 550.42m | 60.53m | 1.34bn | 4.08k | 22.85 | 2.56 | 15.05 | 2.44 | 1.92 | 1.92 | 17.43 | 17.09 | 0.739 | 5.88 | 6.49 | 134,874.30 | 8.13 | 4.48 | 9.46 | 5.33 | 34.68 | 34.71 | 11.00 | 5.86 | 2.67 | -- | 0.1136 | 17.23 | -6.21 | 3.19 | 1.61 | 5.56 | -12.35 | 0.00 |
| Integra Lifesciences Holdings Corp | 1.54bn | 67.74m | 2.28bn | 3.95k | 34.32 | 1.43 | 11.91 | 1.48 | 0.8444 | 0.8444 | 19.19 | 20.31 | 0.4019 | 1.59 | 5.79 | 390,667.30 | 1.77 | 3.33 | 1.92 | 3.68 | 63.09 | 63.67 | 4.39 | 7.99 | 2.18 | 7.95 | 0.4857 | 0.00 | -1.03 | 0.9219 | -62.48 | 2.19 | -2.97 | -- |
| OSI Systems, Inc. | 1.37bn | 113.62m | 2.38bn | 6.24k | 21.19 | 3.08 | 15.54 | 1.74 | 6.58 | 6.58 | 79.29 | 45.29 | 0.8565 | 2.18 | 3.95 | 218,997.90 | 7.12 | 6.23 | 11.63 | 9.18 | 35.61 | 35.69 | 8.31 | 7.07 | 0.7957 | 7.25 | 0.3723 | 0.00 | 8.04 | 3.25 | -20.43 | 47.89 | -6.71 | -- |
| Mirion Technologies Inc | 800.90m | -96.90m | 2.50bn | 3.00k | -- | 1.69 | 39.08 | 3.13 | -0.4993 | -0.4993 | 4.08 | 6.57 | 0.2935 | 3.09 | 3.62 | 266,966.70 | -3.62 | -- | -4.10 | -- | 44.50 | -- | -12.32 | -- | 1.48 | -0.1691 | 0.3068 | -- | 11.58 | -- | 65.01 | -- | -- | -- |
| Olink Holding AB (publ) - ADR | 169.60m | -31.60m | 2.74bn | 707.00 | -- | -- | -- | 16.15 | -0.2547 | -0.2547 | 1.36 | -- | 0.3145 | 0.9963 | 2.94 | 239,882.60 | -5.86 | -- | -6.40 | -- | 67.49 | -- | -18.63 | -- | 3.55 | -- | 0.0506 | -- | 21.27 | -- | -145.90 | -- | -- | -- |
| Badger Meter Inc | 740.77m | 102.31m | 5.32bn | 2.14k | 52.18 | 9.94 | 40.44 | 7.18 | 3.47 | 3.47 | 25.13 | 18.22 | 1.08 | 3.07 | 8.39 | 346,154.70 | 14.86 | 12.26 | 18.17 | 14.60 | 39.26 | 39.38 | 13.81 | 12.06 | 2.30 | -- | 0.00 | 36.36 | 24.40 | 10.16 | 39.25 | 27.22 | 6.79 | 12.07 |
| Vontier Corp | 3.10bn | 376.90m | 6.21bn | 8.00k | 16.63 | 6.96 | 12.38 | 2.01 | 2.42 | 2.42 | 19.84 | 5.77 | 0.7167 | 5.18 | 6.12 | 386,900.00 | 8.73 | 10.80 | 11.18 | 14.04 | 46.24 | 44.62 | 12.18 | 13.36 | 1.08 | 5.80 | 0.7194 | 2.24 | -2.80 | 3.03 | -6.08 | -0.5018 | 7.23 | -- |
| Cognex Corp | 837.55m | 113.23m | 6.73bn | 2.99k | 60.03 | 4.47 | 49.81 | 8.04 | 0.6525 | 0.6525 | 4.83 | 8.77 | 0.4213 | 1.66 | 6.67 | 279,928.80 | 5.70 | 10.63 | 6.23 | 11.56 | 71.79 | 72.97 | 13.52 | 22.38 | 3.40 | -- | 0.00 | 57.03 | -16.75 | 0.7624 | -47.46 | -13.24 | -9.06 | 9.03 |
| MKS Instruments Inc | 3.62bn | -1.84bn | 7.36bn | 10.00k | -- | 2.97 | -- | 2.03 | -27.56 | -27.56 | 54.17 | 36.95 | 0.3513 | 2.01 | 5.19 | 362,100.00 | -17.86 | -1.60 | -19.57 | -1.75 | 45.35 | 44.95 | -50.84 | -3.25 | 2.01 | 1.16 | 0.6596 | -- | 2.11 | 11.78 | -652.85 | -- | 6.69 | 2.44 |
| Bio Rad Laboratories Inc | 2.67bn | -637.32m | 9.42bn | 8.03k | -- | 0.9139 | -- | 3.52 | -21.49 | -21.49 | 91.24 | 306.51 | 0.2071 | 1.65 | 5.43 | 332,660.30 | -4.94 | 9.08 | -5.16 | 9.60 | 53.56 | 55.55 | -23.86 | 41.97 | 4.34 | 0.3095 | 0.1207 | 0.00 | -4.67 | 3.13 | 82.43 | -- | 3.83 | -- |
Data as of Apr 23 2024. Currency figures normalised to Integra Lifesciences Holdings Corp's reporting currency: US Dollar USD
45.78%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Dec 2023 | 6.91m | 8.83% |
| BlackRock Fund Advisorsas of 31 Dec 2023 | 5.88m | 7.52% |
| Capital Research & Management Co. (Global Investors)as of 31 Dec 2023 | 4.30m | 5.49% |
| Wellington Management Co. LLPas of 31 Dec 2023 | 3.19m | 4.07% |
| Boston Management & Researchas of 31 Dec 2023 | 2.96m | 3.78% |
| Cooke & Bieler LPas of 31 Dec 2023 | 2.83m | 3.62% |
| AllianceBernstein LPas of 31 Dec 2023 | 2.73m | 3.48% |
| ClearBridge Investments LLCas of 31 Dec 2023 | 2.47m | 3.16% |
| Champlain Investment Partners LLCas of 31 Dec 2023 | 2.44m | 3.11% |
| SSgA Funds Management, Inc.as of 31 Dec 2023 | 2.12m | 2.71% |
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
